Hey glendronach, hope you are enjoying a nice glass of the finest. It feels like the end of an era.
I think,as you do, it probably comes down to a difference of vision.
As to who will read the 3d seismic and decide where to stick the bit, that will come down to what Tony Cortis and co decide to do. Hopefully they stick around should the company keep going
I, too, have considered the possibility that Macquarie raised concerns about SN prior to finalising finance (an issue raised by dabble) as a potential explanation for his sudden departure but put it in the “possible but unlikely” basket. After all, the last announcement suggests finance was all but agreed.
I think the simplest explanation, until proven otherwise, is the most likely: that there was a difference of opinions between SN and the board on the best way forward.
- Forums
- ASX - By Stock
- STX
- Ann: CEO Transition and Strategic Review
STX
strike energy limited
Add to My Watchlist
6.90%
!
13.5¢

Ann: CEO Transition and Strategic Review, page-76
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
-0.010(6.90%) |
Mkt cap ! $387.0M |
Open | High | Low | Value | Volume |
15.0¢ | 15.0¢ | 13.5¢ | $2.140M | 15.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1817992 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 2335247 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1669844 | 0.135 |
18 | 1154387 | 0.130 |
4 | 153042 | 0.125 |
5 | 190852 | 0.120 |
2 | 46080 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 1050310 | 3 |
0.145 | 1442309 | 3 |
0.150 | 1697750 | 8 |
0.155 | 893309 | 8 |
0.160 | 3347291 | 13 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online